Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ZTS vs MRNA✓SelectedUSD · MRNAZTS vs MRNA performance historyLatest closeAs of-5.59%11/19
Stock and ETF performance explorer

ZTS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-0.7%
MRNA return
+806.0%
Excess return
-806.8%
Maximum drawdown
-70.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-5.6%+1.3%-6.9%-5.6%
7D-2.6%-13.8%+11.2%-2.0%
30D+1.6%-17.7%+19.3%+2.4%
3M+6.1%+14.3%-8.2%+4.8%
6M+3.8%+336.0%-332.2%-7.7%
YTD-34.3%+575.9%-610.3%-43.7%
1Y-29.4%+724.4%-753.8%-40.4%
3Y-51.6%+160.8%-212.4%-57.0%
5Y-62.0%-24.4%-37.6%-64.8%
All-0.7%+806.0%-806.8%-18.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling